The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and feasibility of outpatient induction chemotherapy with CPX-351 in selected older adult patients with newly diagnosed AML.
 
Timothy Edward Kubal
No Relationships to Disclose
 
Christopher Salamanca
No Relationships to Disclose
 
Rami S. Komrokji
Stock and Other Ownership Interests - Abbvie
Consulting or Advisory Role - Celgene; Novartis
Speakers' Bureau - Alexion Pharmaceuticals; Novartis
Research Funding - Boehringer Ingelheim (Inst); Celgene (Inst); Eleos (Inst); GlaxoSmithKline (Inst); Incyte (Inst)
Travel, Accommodations, Expenses - Alexion Pharmaceuticals; Celgene; Incyte; Novartis
 
David A Sallman
Speakers' Bureau - Celgene
Research Funding - Celgene
 
Kendra Lynn Sweet
Leadership - Immtech (I)
Honoraria - Novartis
Consulting or Advisory Role - Agios; ARIAD; Karyopharm Therapeutics; Novartis; Otsuka; Pfizer
Speakers' Bureau - ARIAD; Celgene; Jazz Pharmaceuticals; Novartis
Research Funding - Incyte (Inst); Karyopharm Therapeutics (Inst)
Travel, Accommodations, Expenses - ARIAD; Karyopharm Therapeutics; Novartis; Otsuka; Pfizer
 
Eric Padron
Honoraria - Incyte; Karyopharm Therapeutics
Research Funding - Cell Therapeutics (Inst); Incyte (Inst)
 
Alan F. List
Honoraria - Celgene
Consulting or Advisory Role - Aileron Therapeutics; Amphivena; Celgene; Cellular Biomedicine Group; Jazz Pharmaceuticals; Strategia
Research Funding - Celgene
Travel, Accommodations, Expenses - Celgene
 
Jeffrey E. Lancet
Consulting or Advisory Role - Astellas Pharma; Bio-Path Holdings, Inc; Biosight; Celgene; ERYTECH Pharma; Janssen; Jazz Pharmaceuticals
Research Funding - Pfizer (Inst)